Physician profile

David Bartlett

Surgical Oncology · Pittsburgh, PA

NPI 1952373862

$2,306.02

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$130.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Illumina, INC. $1,637.40 2022
Elekta, INC. $201.86 2021-2022
Intera Oncology, INC $153.62 2021
Intuitive Surgical, INC. $129.75 2022
Olympus America INC. $109.04 2024 Hanarostent Esophagus Tts(Ccc)
E.R. Squibb & Sons, L.L.C. $52.63 2020
Ethicon US, LLC $21.72 2023 Certus 140

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Bartlett

$2,306.02

in general payments reported 2019-2025

Years
2020-2024
Top company
Illumina, INC.

https://glasscript.com/doctor/270325/david-bartlett

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.